Skip to main
ADUS
ADUS logo

Addus HomeCare (ADUS) Stock Forecast & Price Target

Addus HomeCare (ADUS) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 33%
Buy 60%
Hold 0%
Sell 7%
Strong Sell 0%

Bulls say

Addus HomeCare Corp is poised for strong future growth, driven by a healthy expansion of its Hospice segment, which reported a significant year-over-year revenue increase of 7.8%, with expectations to reach the high end of 5-7% growth in the upcoming periods. The Home Health segment continues to show positive momentum with a 1.6% year-over-year revenue increase, and management anticipates a growth outlook for Personal Care Services at the high end of 3-5% due to easing Medicaid disruptions and normalization of admissions. Furthermore, consensus estimates for 2025 reflect a notable uptick, with revenue, EBITDA, and EPS expectations rising by 11%, 15%, and 8% respectively, indicating a solid market confidence in Addus's strategic initiatives and acquisition opportunities.

Bears say

Addus HomeCare Corp has experienced a decline in key operational metrics, with Home Health volumes showing a negative same-store growth of -3.2% year-over-year and new admissions decreasing by -6.2%. Additionally, the company's financial performance is under pressure, evidenced by total visits in Home Health falling by -4.2% year-over-year and a reduction in adjusted EBITDA estimates for 2025-2027, reflecting a downward trend in profitability. Furthermore, expectations of gross margin compression in the upcoming quarter, driven by a mix shift from the inclusion of Gentiva and seasonal payroll effects, further exacerbate the company's weak financial outlook.

Addus HomeCare (ADUS) has been analyzed by 15 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 60% recommend Buy, 0% suggest Holding, 7% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Addus HomeCare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Addus HomeCare (ADUS) Forecast

Analysts have given Addus HomeCare (ADUS) a Buy based on their latest research and market trends.

According to 15 analysts, Addus HomeCare (ADUS) has a Buy consensus rating as of Aug 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $118.27, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $118.27, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Addus HomeCare (ADUS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.